CenExel

After over a year of planning, construction, and navigating permits, the day has finally arrived! We’re thrilled to announce the grand opening of the second expansion at CenExel ACT. This new 8,000 sq ft addition brings exciting enhancements to our facility, including onsite safety laboratory capability, an expanded PBMC lab now capable of processing up to 100 samples per day, and two spacious flex areas that can house additional beds (e.g. QT trials or support extended outpatient visits) and a much smoother admission and confinement flow. This milestone wouldn’t have been possible without the dedication and hard work of everyone involved—thank you to our amazing team, partners, and supporters! Drop by and give us a visit! #ClinicalResearch #Expansion #CenExelACT

Exciting News! Zach Mitchell has been promoted to Chief Sales Officer at #CenExel! With over a decade in clinical research, he will lead our business development strategy, drive growth, and strengthen industry partnerships. “The future of CenExel is bright, and I’m honored to be part of shaping it,” says Zach. Join us in congratulating Zach on this well-earned promotion! #Leadership #ClinicalResearch #ClinicalTrials

#CenExel is honored to be in the running for the?Best Clinical Trial Network Award?at the 18th Annual VIE Awards! Your support can help us secure a spot on the shortlist and bring home this prestigious recognition. ? This award celebrates clinical trial networks that deliver?high-quality data, predictable enrollment, and diverse trial support—all values that define CenExel. We are committed to advancing clinical research through?performance improvements, innovative services, and operational excellence across our network. ? Voting is quick and easy: Visit the?voting link here: https://lnkd.in/e8ad9A_4 Click on?"Best Clinical Trial Network." Find?CenExel?and select?"Vote Here." Enter your?name, company, email, and location. Hit?submit—you’re done! ? Voting is open until?February 23rd, so don’t wait! Every vote counts in recognizing CenExel’s dedication to excellence in clinical research. Thank you for your support!

CenExel is excited to share that several members of our exceptional leadership are in Washington, DC for ISCTM! As leaders in CNS clinical research, our team is committed to driving innovation and improving trial methodologies to bring better treatments to patients faster. We look forward to seeing you! #CenExel #ISCTM2025 #ClinicalResearch

?? Spotlight on Leadership: Why Multisite Research Organizations Need Advocacy Now More Than Ever Our Executive Director, Jim Kremidas, writes for DIA Global on the driving forces behind the creation of AMRC (Association of Multisite Research Corporations) and the unique role we play in advancing the interests of sponsors, CROs, and the multisite research community. ?? Key topics covered include: - The rapid evolution of clinical trials and how multisite organizations are transforming the research landscape. - Why collaboration, standardization, and advocacy are critical for ensuring operational excellence and regulatory alignment. - How a trade association like AMRC bridges the gap between sponsors and CROs to drive efficiency and innovation in research. We’re proud to stand as the unified voice for multisite clinical research organizations, championing the tools, policies, and partnerships that fuel their success. ?? ?? Read the full op-ed here: https://lnkd.in/gumQ4Xhm We’d love to hear your thoughts—how do you see the future of multisite research evolving? Join the conversation in the comments! #ClinicalResearch #MultisiteTrials #CROs #Sponsors #ResearchInnovation #AMRC #Advocacy #DIAForum

AMRC Executive Director, Jim Kremidas, spoke to Dan Schell, Editor of Clinical Leader on the launch of our association dedicated to serving the needs of Multisite Clinical Research Corporations (MCRCs). Here are a few key facts about the AMRC, outline by Dan: - Members must have at least five sites in their network - Clinical research must be a member’s primary business - It is a paid membership - There are 14 founding organizations who have a global footprint of more than 370 research sites and >900 PIs Read the full article here: https://lnkd.in/e9xyKCcp #ClinicalResearch #TradeAssociation #MCRCs #MultisiteResearch

CenExel is excited to be a part of such an incredible trial!

??#SCOPESummit2025 Coverage Interactive panel on day 1 of #SCOPESummit 2025 highlighted the need for inclusive narratives, social listening to understand patient experiences, and the role of advocacy groups in opening doors to #clinicaltrials. The panel's participants included Emily McCormack, social media director, New York Blood Center; Quynh Tu Tran, MPH, director of patient activation, Cystic Fibrosis Foundation; Fabian Sandoval, MD, president & CEO, Emerson Clinical Research Institute; and Darious Davis, senior director of business development, CenExel The discussion was moderated by T Hephner, CRO, Inspire

Did you get a chance to see Jessica McCoun, M.D., Principal Investigator at CenExel Georgia, on CNN this weekend? If you missed it or would like to watch it again, we've got you covered! Check it out to learn more about Vertex Pharmaceuticals' Journavx?, the FDA's first approved non-opioid moderate to severe pain treatment in 25 years. Watch now: https://lnkd.in/esB8SAGP Congratulations again to Vertex, Dr. McCoun, and all of the teams involved to bring this important drug to fruition! #CenExel #Vertex #Journavx

Did you hear about the incredible new non-opioid acute pain treatment that was just approved by the FDA? Are you near a tv? In just about an hour, CenExel Atlanta’s exceptional Principal Investigator, Jessica McCoun, M.D., will be interviewed about this exceptional new drug on CNN by Fredericka Whitfield! Make sure to tune in to hear Dr. McCoun discuss the clinical research involved in the development of Vertex’s Journavx? and how CenExel supported the trials! See you all on CNN! #cenexel #cnn #journavx